Mayo Clinic Ventures
Private equity
Active
Rochester, United States
38
18M
27
1.00
5
0.29
3
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main department of described VC is located in the Rochester.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Mayo Clinic Ventures works on 8 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. The high activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Mayo Clinic Ventures, startups are often financed by Sanderling Ventures, Thomas, McNerney & Partners, i2E. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Thomas, McNerney & Partners, Accuitive Medical Ventures. In the next rounds fund is usually obtained by Sanderling Ventures, Thomas, McNerney & Partners, Accuitive Medical Ventures.
We also calculated 1 valuable employee in our database.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Torax Medical, Qlaris Bio, Cadence Neuroscience The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Investor highlights
- Check size
- Up to 20M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 38
- Lead investments
- 5
- Exits
- 3
- Rounds per year
- 1.00
- Follow on index
- 0.29
- Investments by industry
- Health Care (32)
- Biotechnology (27)
- Medical (12)
- Therapeutics (10)
- Medical Device (9) Show 31 more
- Investments by region
-
- United States (34)
- China (1)
- Israel (1)
- Ireland (2)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 0.87
- Avg. company exit year
- 15
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
JOGO Health | 30 Aug 2021 | Biotechnology, Fitness, Health Care, Pharmaceutical | Seed | 4M | United States, New Jersey, Bridgewater |
Qlaris Bio | 30 Apr 2024 | Biotechnology, Health Care, Medical | Early Stage Venture | 24M | United States, Massachusetts, Cambridge |
YoQueVos | 01 Sep 2011 | Beauty, Fashion, Women's | Seed | 25K | Argentina, Entre Ríos Province |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.